Your town. Your news. Your take.

Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

 
Advertisment
Biomira

May 5, 2008

Oncothyreon Files Investigational New Drug Application For PX-866...

“PX-866 is a potent inhibitor of phosphatidylinositol-3-kinase that has demonstrated preclinical anti-tumor activity in models of human ovarian cancer, lung cancer and intracranial glioblastoma”

Oncothyreon Inc. recently announced that it has filed an investigational new drug application with the U.S. Food and Drug Administration for PX-866, a small molecule phosphatidylinositol-3-kinase inhibitor for ... via Pharmaceutical Online

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.